Table 6.
Complications, recurrences, and followup periods of patients according to groups.
| Group A (n : 38) | Group B (n : 36) | Group C (n : 26) | P | |
|---|---|---|---|---|
| Complication | 4 (10%) | 2 (5%) | 4 (15%) | ≤0.01 |
| Major | 2 (5%) | 1 (2.5%) | 2 (7%) | ≤0.01 |
| Minor | 2 (5%) | 1 (2.5%) | 2 (7%) | ≤0.01 |
| Recurrences and etiology | 10 (26%) | 3 (8%) | 3 (11%) | ≤0.01 |
| Tuberculosis | 6 (16%) | 0 | 0 | ≤0.01 |
| Malignancy | 3 (8%) | 0 | 0 | ≤0.01 |
| İdiopathic | 1 (2%) | 3 (8%) | 3 (11%) | ≤0.01 |
| 30-day mortality rate | 2 (5%) | 1 (3%) | 2 (8%) | ≤0.01 |
| Exitus | 5 (13%) | 3 (8%) | 4 (15%) | ≤0.01 |
| Coagulopathy | 1 (2.6%) | 0 | 1 (4%) | ≤0.01 |
| Ischemic heart disease and cardiac failure | 1 (2.6%) | 0 | 0 | ≤0.01 |
| Tuberculosis | 1 (2.6%) | 0 | 0 | ≤0.01 |
| Malignancy | 2 (5% ) | 3 (8%) | 3 (11%) | ≤0.01 |
| Complete followup | 36 (94%) | 34 (94%) | 24 (92%) | NS |